Trakeze 1 mL Solution for injection or infusion.
PDF Leaflet Revision Date: 22 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to general anaesthesia for tracheal intubation and muscle relaxation.
Dosage (summary)
Standard intubation dose: 0.6 mg/kg; maintenance: 0.15 mg/kg.
Onset of Action / Duration
Onset: 60-90 secs, Duration: 30-110 mins depending on dose.
Special Populations
- Elderly patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; limited placental transfer.
Key Drug Interactions
- Inhalation anaesthetics potentiate effects
- Corticosteroids may prolong neuromuscular block
Contraindications
- Hypersensitivity to rocuronium
- Inadequate data in neonates
- Not recommended in paediatric and elderly ICU patients
Common side effects
- Injection site pain
- Tachycardia
- Prolonged neuromuscular block
Counselling Points
- Monitor for respiratory function post-administration
- Avoid driving or operating machinery for 24 hours post-recovery
- Report any allergic reactions immediately
Serious warnings
- Mandatory ventilatory support required
- Risk of anaphylaxis
- Potential for residual neuromuscular blockade
Important Disclaimer
The Trakeze 1 mL Solution for injection or infusion. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
